34,538,185 and 26,788,986 shares
issued and outstanding 35 27
Treasury stock, 433,333 shares, at cost (433) (433)
Additional paid-in capital 275,782 241,389
Accumulated other comprehensive income 124 14
Accumulated deficit (242,417) (221,524)
---------- ---------
Total Shareholders' Equity 33,091 19,473
---------- ---------
TOTAL LIABILITIES AND SHAREHOLDERS'
EQUITY $ 40,270 $ 27,893
========== =========
The accompanying notes are an integral part of these
condensed financial statements.
Genelux Corporation
Condensed Statements of Operations
(in thousands, except for share amounts and per share
data)
Three Months Ended Nine Months Ended
September 30, September 30,
-------------------------- ----------------------------
2024 2023 2024 2023
(Unaudited) (Unaudited)
Revenues $ - $ - $ 8 $ 170
---------- ---------- ---------- ----------
Operating
expenses:
Research and
development 4,051 2,819 12,478 8,607
General and
administrative 2,890 2,488 9,478 8,727
---------- ---------- ---------- ----------
Total operating
expenses 6,941 5,307 21,956 17,334
---------- ---------- ---------- ----------
Loss from
operations (6,941) (5,307) (21,948) (17,164)
---------- ---------- ---------- ----------
Other income
(expenses):
Interest income 474 4 1,055 4
Interest
expense - - - (167)
Debt discount
amortization - - - (649)
Financing costs - (42) - (3,152)
Debt
extinguishment
costs - (402)
Total other
income
(expenses), net 474 (38) 1,055 (4,366)
---------- ---------- ---------- ----------
NET LOSS $ (6,467) $ (5,345) $ (20,893) $ (21,530)
========== ========== ========== ==========
LOSS PER COMMON
SHARE - BASIC
AND DILUTED $ (0.19) $ (0.20) $ (0.69) $ (0.91)
========== ========== ========== ==========
WEIGHTED-AVERAGE
COMMON SHARES
OUTSTANDING -
BASIC AND
DILUTED 34,532,355 26,210,068 30,405,615 23,640,995
========== ========== ========== ==========
The accompanying notes are an integral part of these
condensed financial statements.
Genelux Corporation
Condensed Statements of Comprehensive Loss
(in thousands)
Three Months Ended Nine Months Ended
September 30, September 30,
------------------ ----------------------
2024 2023 2024 2023
(Unaudited) (Unaudited)
Net loss $(6,467) $(5,345) $(20,893) $(21,530)
Other
comprehensive
loss:
Net unrealized
gain on short
and long-term
investments 135 - 110 -
Comprehensive
loss $(6,332) $(5,345) $(20,783) $(21,530)
====== ====== ======= =======
The accompanying notes are an integral part of these
condensed financial statements.
(END) Dow Jones Newswires
November 14, 2024 16:05 ET (21:05 GMT)
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。